Advertisement
Castlight Health, Inc.

Castlight Health, Inc. Fundamental Analysis

CSLTNYSE
HealthcareMedical - Healthcare Information Services
$2.05
$0.010(0.49%)
U.S. Market is Open · 15:30
Advertisement

Castlight Health, Inc. Fundamental Analysis

Castlight Health, Inc. (CSLT) shows weak financial fundamentals with a PE ratio of -4.99, profit margin of -42.39%, and ROE of -41.91%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.05
Current Ratio2.47

Areas of Concern

ROE-41.91%
Operating Margin-42.80%
We analyze CSLT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -56.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-56.1/100

We analyze CSLT's fundamental strength across five key dimensions:

Efficiency Score

Weak

CSLT struggles to generate sufficient returns from assets.

ROA > 10%
-37.28%

Valuation Score

Excellent

CSLT trades at attractive valuation levels.

PE < 25
-4.99
PEG Ratio < 2
-0.05

Growth Score

Weak

CSLT faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CSLT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.11
Current Ratio > 1
2.47

Profitability Score

Weak

CSLT struggles to sustain strong margins.

ROE > 15%
-4191.08%
Net Margin ≥ 15%
-42.39%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is CSLT Expensive or Cheap?

P/E Ratio

CSLT trades at -4.99 times earnings. This suggests potential undervaluation.

-4.99

PEG Ratio

When adjusting for growth, CSLT's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Castlight Health, Inc. at 2.51 times its book value. This may indicate undervaluation.

2.51

EV/EBITDA

Enterprise value stands at -0.64 times EBITDA. This is generally considered low.

-0.64

How Well Does CSLT Make Money?

Net Profit Margin

For every $100 in sales, Castlight Health, Inc. keeps $-42.39 as profit after all expenses.

-42.39%

Operating Margin

Core operations generate -42.80 in profit for every $100 in revenue, before interest and taxes.

-42.80%

ROE

Management delivers $-41.91 in profit for every $100 of shareholder equity.

-41.91%

ROA

Castlight Health, Inc. generates $-37.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-37.28%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.06 in free cash annually.

$-0.06

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.99

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.51

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.42

vs 25 benchmark

ROA

Return on assets percentage

-0.37

vs 25 benchmark

ROCE

Return on capital employed

-0.47

vs 25 benchmark

How CSLT Stacks Against Its Sector Peers

MetricCSLT ValueSector AveragePerformance
P/E Ratio-4.9934.27 Better (Cheaper)
ROE-41.91%377.00% Weak
Net Margin-42.39%-42945.00% (disorted) Weak
Debt/Equity0.110.78 Strong (Low Leverage)
Current Ratio2.475.54 Strong Liquidity
ROA-37.28%-162.00% (disorted) Weak

CSLT outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Castlight Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ